Hyperbaric oxygen therapy: medical uses versus wellness claims

Hyperbaric oxygen therapy combines increased chamber pressure with high-concentration oxygen under a defined medical protocol. Recognized uses include selected conditions such as decompression sickness, carbon-monoxide poisoning, certain nonhealing wounds, and radiation injury. Generic anti-aging, detox, performance, autism, cancer-cure, or wellness claims should not borrow credibility from those uses.

The phrase “more oxygen” leaves out the treatment’s defining elements. A medical protocol specifies chamber pressure, oxygen concentration and delivery method, exposure time, air breaks when used, treatment schedule, diagnosis, monitoring, and emergency procedures. A soft chamber at a modest pressure using room air is not interchangeable with a hospital protocol at a different pressure using medical oxygen. ¹²³

Pressure is only one line of the prescription

FDA describes HBOT devices as Class II devices cleared through 510(k) and warns of rare serious injuries and deaths, including fires. Pressure increases oxygen exposure but also creates barotrauma, oxygen-toxicity, and fire-safety considerations.

Monoplace chambers usually hold one person; multiplace systems can hold several people and deliver oxygen through a mask, hood, or other system. Chamber construction, maximum operating pressure, gas supply, patient interface, monitoring, and decompression controls determine what the device can do. “Hard” and “mild” are marketing shortcuts unless the actual atmosphere and pressure in atmospheres absolute are stated.

Pressure increases the amount of oxygen dissolved in plasma when high-concentration oxygen is breathed. That mechanism supports defined medical uses under clinical protocols; it does not establish that every tissue needs extra oxygen or that more sessions improve an otherwise healthy person. An oxygen concentrator used without meaningful pressurization is also not equivalent to HBOT.

Treatment of a nonhealing diabetic wound, for example, is not simply a chamber visit. It can sit within wound assessment, vascular evaluation, infection management, off-loading, glucose care, and a protocol matched to the condition. Removing that clinical system and selling the chamber session as “wellness” removes much of what made the medical evidence relevant.

Recognized indications do not validate a wellness list

A chamber’s legal marketing status does not establish efficacy for every condition placed on a menu. “FDA registered” is not the same as cleared. Studies of one pressure, oxygen concentration, and diagnosis cannot validate lower-pressure wellness protocols.

The Undersea and Hyperbaric Medical Society lists accepted indications such as air or gas embolism, carbon-monoxide poisoning, clostridial myositis and myonecrosis, crush injury and acute traumatic ischemias, decompression sickness, selected arterial insufficiencies and wounds, severe anemia, intracranial abscess, necrotizing soft-tissue infection, refractory osteomyelitis, delayed radiation injury, compromised grafts or flaps, acute thermal burns, and idiopathic sudden sensorineural hearing loss. Each is a defined medical problem, not evidence for general recovery or longevity.

Claims about anti-aging, detoxification, athletic performance, post-travel fatigue, autism, Alzheimer’s disease, cancer cure, or routine immune enhancement need direct evidence for that population and exact protocol. Improvement in one laboratory marker under pressure does not prove better daily function, disease outcome, or lifespan. A testimonial after dozens of sessions does not supply a control group or distinguish chamber effects from concurrent care.

Protocol transfer is a central limit. Results at one pressure, oxygen fraction, session duration, number of treatments, and diagnosis do not validate a lower-pressure package. Ask how many participants were studied, what comparison they received, how the outcome was measured, and whether adverse events and incomplete follow-up were reported.

Device clearance and treatment indication are separate

FDA describes hyperbaric chambers as Class II medical devices that generally require 510(k) clearance. Request the manufacturer, model, clearance number, intended use, operating limits, and current maintenance record. A device establishment being registered, a chamber being listed, or an imported system using medical-looking language does not mean FDA has cleared every condition on the facility’s menu.

Medical oxygen is a drug, while the pressure vessel is a device; the delivered treatment involves both plus a clinical protocol. A facility should state whether the chamber contains oxygen or air, how oxygen is delivered and measured, who writes or reviews the treatment order, and whether the proposed condition is an accepted indication, another medically supervised use, or a wellness claim.

Material risks and response planning

Ear or sinus barotrauma, temporary vision change, pulmonary effects, oxygen toxicity and seizures, glucose monitoring in diabetes, confinement concerns, and fire are material. Clothing, electrical devices, skin products, maintenance, grounding, staff training, and emergency decompression are operational safety issues. ⁴

The cited safety review describes pressure-related injury to ears, sinuses, teeth, and lungs; inability to equalize is not a discomfort challenge to push through. Oxygen exposure can contribute to temporary vision changes and, rarely, seizures or pulmonary toxicity. People with diabetes need a protocol-specific glucose and hypoglycemia plan. Device compatibility and confinement tolerance also belong in screening rather than being discovered after compression begins.

Fire is the distinctive catastrophic hazard because enriched oxygen accelerates combustion. FDA’s 2025 letter followed reports of serious injury and death and stresses following manufacturer instructions, fire prevention, maintenance, grounding, staff training, and control of prohibited items. Clothing, dressings, hair and skin products, electronics, batteries, heating items, and medical equipment need formal screening—not a casual request to remove a phone.

Ask how staff continuously observe and communicate with the occupant, manage ear pain or neurologic symptoms, perform emergency decompression, respond to fire, and transfer someone who becomes ill. The chart should record chamber model, pressure, gas and oxygen delivery, duration, air breaks, operator, indication, pre-session screening, and any event.

Questions before any chamber series

1. 1. What diagnosis justifies pressurized oxygen? Ask who established it, how HBOT fits the rest of care, and whether a recognized-indication guideline applies.
2. 2. Which chamber will actually be used? Record model, clearance, monoplace or multiplace design, rated pressure, gas environment, oxygen interface, and maintenance.
3. 3. What is the complete exposure prescription? Use atmospheres absolute, oxygen concentration, minutes at pressure, air breaks, compression and decompression, and number of visits.
4. 4. Who is clinically responsible during the session? Identify the ordering or supervising clinician, trained operator, monitoring method, after-hours contact, and transfer pathway.
5. 5. How is fire risk controlled every time? Review clothing, products, dressings, devices, prohibited items, grounding, inspection, staff drills, and emergency decompression.
6. 6. Does the evidence reproduce this protocol and outcome? Do not use accepted-indication evidence to validate a different pressure, healthy population, vague wellness endpoint, or sales bundle.

Medical context is the dividing line

Ask the facility to state the diagnosis, device 510(k), chamber type, pressure in ATA, oxygen concentration and delivery, session duration, air breaks, supervising clinician, monitoring, emergency response, and evidence for the exact claim.

Recognized HBOT is delivered because a diagnosed condition and evidence-informed protocol justify a pressure-and-oxygen exposure within coordinated care. Wellness HBOT starts from a desired feeling or broad promise and then searches for scientific language. That inversion should trigger closer scrutiny, not automatic purchase.

A series can require many visits, travel, preparation, ear-clearing ability, glucose planning, and time in a confined device. Before committing, define the clinical endpoint and the review point at which nonresponse ends the series. For a general wellness claim, compare that burden with ordinary recovery practices or medical evaluation of the underlying symptom.

The chamber is not the treatment claim. The complete proposition is diagnosis plus device plus pressure plus oxygen plus supervision plus outcome. If any of those fields is missing—or if amenities and testimonials replace fire controls and protocol evidence—the service has not earned the medical credibility implied by “hyperbaric oxygen therapy.”